HUE052793T2 - Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny - Google Patents

Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny

Info

Publication number
HUE052793T2
HUE052793T2 HUE19151359A HUE19151359A HUE052793T2 HU E052793 T2 HUE052793 T2 HU E052793T2 HU E19151359 A HUE19151359 A HU E19151359A HU E19151359 A HUE19151359 A HU E19151359A HU E052793 T2 HUE052793 T2 HU E052793T2
Authority
HU
Hungary
Prior art keywords
carboxymethylcellulose
sodium hyaluronate
artificial tears
tears
artificial
Prior art date
Application number
HUE19151359A
Other languages
English (en)
Inventor
Bereth J Beard
Wendy M Blanda
David A Marsh
Peter A Simmons
Joseph Vehige
Liu Haixia
Steven S Matsumoto
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HUE052793T2 publication Critical patent/HUE052793T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE19151359A 2013-02-01 2014-02-03 Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny HUE052793T2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759710P 2013-02-01 2013-02-01
US201361785857P 2013-03-14 2013-03-14

Publications (1)

Publication Number Publication Date
HUE052793T2 true HUE052793T2 (hu) 2021-05-28

Family

ID=50113045

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE19151359A HUE052793T2 (hu) 2013-02-01 2014-02-03 Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny
HUE14704747 HUE044555T2 (hu) 2013-02-01 2014-02-03 Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE14704747 HUE044555T2 (hu) 2013-02-01 2014-02-03 Nátrium-hialuronátot és karboximetil-cellulózt tartalmazó mûkönny

Country Status (24)

Country Link
US (3) US20140221309A1 (hu)
EP (2) EP3517100B1 (hu)
JP (2) JP6527468B2 (hu)
KR (1) KR102227202B1 (hu)
CN (2) CN104981234A (hu)
AU (2) AU2014212025A1 (hu)
BR (1) BR112015018414B1 (hu)
CA (1) CA2898217C (hu)
CY (1) CY1124054T1 (hu)
DK (2) DK3517100T3 (hu)
ES (2) ES2741141T3 (hu)
HK (1) HK1218517A1 (hu)
HR (1) HRP20191382T1 (hu)
HU (2) HUE052793T2 (hu)
LT (1) LT2950783T (hu)
MX (1) MX367461B (hu)
PL (2) PL3517100T3 (hu)
PT (2) PT3517100T (hu)
RS (1) RS59271B1 (hu)
RU (1) RU2687275C2 (hu)
SA (1) SA517381008B1 (hu)
SI (2) SI3517100T1 (hu)
WO (1) WO2014121232A1 (hu)
ZA (1) ZA201505026B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6357228B2 (ja) 2013-07-10 2018-07-11 マトリックス バイオロジー インスティテュート 高い弾性を有するヒアルロナンの組成物およびその使用
US9694084B2 (en) 2014-12-23 2017-07-04 Dana-Farber Cancer Institute, Inc. Methods to induce targeted protein degradation through bifunctional molecules
US20170014339A1 (en) * 2015-07-17 2017-01-19 i.com medical GmbH Tear Substitute, Fluid for Being Used as a Tear Substitute, and Method for Producing a Tear Substitute
WO2017053339A1 (en) 2015-09-24 2017-03-30 Matrix Biology Institute High elasticity hyaluronan compositions and methods of use thereof
WO2017075019A1 (en) * 2015-10-28 2017-05-04 Welch David B Eye drops
ES2621877B1 (es) * 2016-01-04 2018-05-04 Agencia Pública Empresarial Sanitaria Hospital De Poniente Solución para resección endoscópica
US10632202B2 (en) * 2016-03-04 2020-04-28 Johnson & Johnson Consumer Inc. Preservative containing compositions
GB201618175D0 (en) * 2016-10-27 2016-12-14 Warneford Healthcare Ltd Pharmaceutical compositions
EP3412276A3 (de) * 2017-06-09 2019-07-17 Omnivision GmbH Zusammensetzung zur behandlung des trockenen auges
JP7457390B2 (ja) * 2018-09-20 2024-03-28 香港科技大学 点眼組成物
KR102051356B1 (ko) * 2019-01-03 2019-12-03 (주)휴온스 고농도의 히알루론산 또는 그의 염을 함유하는 점안 조성물
US11944638B2 (en) 2021-03-10 2024-04-02 Bausch + Lomb Ireland Limited Ophthalmic solutions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5017229A (en) 1990-06-25 1991-05-21 Genzyme Corporation Water insoluble derivatives of hyaluronic acid
US6271216B1 (en) * 1989-07-24 2001-08-07 Allergan Stable solution of hyaluronate in a balanced salt medium
CN1288197C (zh) * 1999-02-19 2006-12-06 电气化学工业株式会社 透明质酸凝胶组合物、其制造方法及含该组合物的医用材料
CA2365767A1 (en) 1999-03-15 2000-09-21 Trustees Of Boston University Angiogenesis inhibition
ES2242643T3 (es) * 1999-11-09 2005-11-16 Alcon Inc. Sales de hidroxieicosatetraenoato, composiciones y metodos de uso en el tratamiento de trastornos del ojo seco.
CA2393354A1 (en) * 1999-12-17 2001-06-21 Timothy J. Butler Surgical prosthesis
CN1485395A (zh) * 2002-09-25 2004-03-31 宋海涛 一种环保型“冷热液”
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
JP2006052160A (ja) * 2004-08-10 2006-02-23 Rohto Pharmaceut Co Ltd ドライアイ治療用眼科組成物
JP2006143590A (ja) * 2004-10-21 2006-06-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20060100173A1 (en) * 2004-11-09 2006-05-11 Powell Charles H Ophthalmic solution
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
KR20090053892A (ko) * 2006-07-25 2009-05-28 오스모티카 코프. 점안액
TWI476022B (zh) * 2006-11-06 2015-03-11 Novartis Ag 隱形眼鏡、其製法及其使用方法
US8609634B2 (en) * 2007-05-16 2013-12-17 Mcneil-Ppc, Inc. Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods
KR100827400B1 (ko) * 2008-06-24 2008-05-06 김정춘 파이프 연결구를 갖는 수도계량기 및 그 제조방법
KR100938500B1 (ko) * 2008-06-24 2010-01-28 주식회사 디에이치피코리아 안과질환 예방 및 치료용 점안제 조성물
US20100086512A1 (en) 2008-10-02 2010-04-08 Rolf Schaefer Mucomimetic compositions and uses therefore
EP2349232A1 (en) * 2008-10-20 2011-08-03 Allergan, Inc. Ophthalmic compositions useful for improving visual acuity
AU2010339993A1 (en) * 2009-12-15 2012-07-26 Foresight Biotherapeutics, Inc. Non-irritating ophthalmic povidone-iodine compositions
CN101785852A (zh) * 2010-01-21 2010-07-28 孙杰 一种真皮层微量介入美容抗衰除皱制剂与方法
CN101884602A (zh) * 2010-03-03 2010-11-17 孙杰 一种皮肤美容修复抗衰除皱的化妆品制剂

Also Published As

Publication number Publication date
RS59271B1 (sr) 2019-10-31
KR102227202B1 (ko) 2021-03-12
PT2950783T (pt) 2019-08-21
ES2741141T3 (es) 2020-02-10
CA2898217A1 (en) 2014-08-07
RU2687275C2 (ru) 2019-05-13
EP3517100A1 (en) 2019-07-31
JP6527468B2 (ja) 2019-06-05
LT2950783T (lt) 2019-10-25
CN111419794A (zh) 2020-07-17
MX367461B (es) 2019-08-21
EP2950783A1 (en) 2015-12-09
HUE044555T2 (hu) 2019-11-28
SA517381008B1 (ar) 2019-08-31
US20220096531A1 (en) 2022-03-31
RU2015132974A (ru) 2017-03-06
HK1218517A1 (zh) 2017-02-24
JP2016507529A (ja) 2016-03-10
BR112015018414A2 (pt) 2017-07-18
AU2018260857B2 (en) 2020-05-07
SI3517100T1 (sl) 2021-02-26
CN104981234A (zh) 2015-10-14
CA2898217C (en) 2021-08-31
ZA201505026B (en) 2016-07-27
HRP20191382T1 (hr) 2019-11-15
DK3517100T3 (da) 2020-12-14
SI2950783T1 (sl) 2019-10-30
ES2841434T3 (es) 2021-07-08
US20140221309A1 (en) 2014-08-07
EP3517100B1 (en) 2020-09-09
JP6876079B2 (ja) 2021-05-26
AU2014212025A1 (en) 2015-08-20
DK2950783T3 (da) 2019-07-22
KR20150113156A (ko) 2015-10-07
PL3517100T3 (pl) 2021-04-19
US20160235780A1 (en) 2016-08-18
EP2950783B1 (en) 2019-05-15
PT3517100T (pt) 2020-12-15
AU2018260857A1 (en) 2018-11-22
PL2950783T3 (pl) 2019-11-29
MX2015009924A (es) 2015-09-25
JP2019112411A (ja) 2019-07-11
CY1124054T1 (el) 2022-03-24
WO2014121232A1 (en) 2014-08-07
BR112015018414B1 (pt) 2022-11-08

Similar Documents

Publication Publication Date Title
HK1218517A1 (zh) 包含透明質酸鈉和羧甲基纖維素的人工淚液
HK1213961A1 (zh) 鉸鏈
EP2948519A4 (en) DELAYED GELIFYING AGENTS
HK1222664A1 (zh) 硫酸乙酰肝素
HK1217452A1 (zh) 含有前列腺胺的眼内植入物
EP2986798A4 (en) HINGE
EP2987933A4 (en) HINGE
SG11201505267SA (en) Jctvc-l0226: vps and vps_extension updates
HK1222572A1 (zh) 包含膠原和透明質酸鈉的藥物組合物
GB201304837D0 (en) Implant trialling
GB2520480B (en) Improvements in hinge assemblies
PT2978326T (pt) Cigarros e a sua construção
HK1221906A1 (zh) 硫酸乙酰肝素
GB201304835D0 (en) Implant trialling
GB201421052D0 (en) Artificial tissue
HK1223555A1 (zh) 用於減少眼內壓的組合物和方法
GB201303796D0 (en) Condom
GB201303131D0 (en) Ocular prosthesis
GB2517211B (en) Conformable tissue expander
EP3003323A4 (en) POLYSACCARIDE COMPOSITIONS AND CORRESPONDING METHODS
ZA201407945B (en) Hinge arrangement
GB201321018D0 (en) Improvements in hinge assemblies